SEARCH

SEARCH BY CITATION

References

  • Adamczak M., Gross M.L., Krtil J. et al. (2003) Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J. Am. Soc. Nephrol. 14, 28332842.
  • Anonymous. (1998) Incidence and prevalence of ESRD – United States Renal Data System. Am. J. Kidney Dis. 32(Suppl. 1), S38S49.
  • Arciniegas E., Sutton A.B., Allen T.D., Schor A.M. (1992) Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J. Cell Sci. 103, 521529.
  • Arciniegas E., Neves C.Y., Carrillo L.M., Zambrano E.A., Ramírez R. (2005) Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development. Endothelium 12, 193200.
  • Ardaillou R., Chansel D., Chatziantoniou C., Dussaule J.C. (1999) Mesangial AT1 receptors: expression, signaling, and regulation. J. Am. Soc. Nephrol. 10(Suppl. 11), S40S46.
  • Belmadani S., Zerfaoui M., Boulares H.A., Palen D.I., Matrougui K. (2008) Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose. Am. J. Physiol. Heart Circ. Physiol. 295, H69H76. Epub 2008 May 2.
  • Berk B.C. (1999) Angiotensin II. J. Am. Soc. Nephrol. 10(Suppl. 11), S62S68.
  • Berk B.C., Fujiwara K., Lehoux S. (2007) ECM remodeling in hypertensive heart disease. J. Clin. Invest. 117, 568575.
  • Boffa J.J., Tharaux P.L., Placier S., Ardaillou R., Dussaule J.C., Chatziantoniou C. (1999) Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism. Circulation 100, 19011908.
  • Boffa J.J., Tharaux P.L., Dussaule J.C., Chatziantoniou C. (2001) Regression of renal vascular fibrosis by endothelin receptor antagonism. Hypertension 37, 490496.
  • Boffa J.J., Ying L., Placier S., Stefanski A., Dussaule J.C., Chatziantoniou C. (2003) Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and metalloproteinases. J. Am. Soc. Nephrol. 14, 11321144.
  • Burns W.C., Kantharidis P., Thomas M.C. (2007) The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 18, 222231.
  • Chatziantoniou C., Boffa J.J., Ardaillou R., Dussaule J.C. (1998) Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: role of endothelin. J. Clin. Invest. 101, 27802789.
  • Cook H.T. (2010) The origin of renal fibroblasts and progression of kidney disease. Am. J. Pathol. 173, 2224.
  • Fakhouri F., Placier S., Ardaillou R., Dussaule J.C., Chatziantoniou C. (2001) Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta. J. Am. Soc. Nephrol. 12, 27012710.
  • Faulkner J.L., Szcykalski L.M., Springer F., Barnes J.L. (2005) Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am. J. Pathol. 167, 11931205.
  • Flamant M., Tharaux P.L., Placier S. et al. (2003) Epidermal growth factor transactivation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J. 17, 327329. Epub 02-0115fje, Dec 2002.
  • Fogo A.B. (2001) Renal fibrosis and the renin-angiotensin system. Adv. Nephrol. Necker Hosp. 31, 6987.
  • François H., Placier S., Flamant M. et al. (2004) Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. FASEB J. 18, 926928. Epub 2004 Mar 19.
  • Frid M.G., Kale V.A., Stenmark K.R. (2002) Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ. Res. 90, 11891196.
  • Harris R.C. & Neilson E.G. (2006) Towards a unified theory of renal progression. Annu. Rev. Med. 57, 365380.
  • Herrero-Fresnada I., Torras J., Franquesa M. et al. (2006) HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int. 70, 265274.
  • Hopkins C., Li J., Rae F., Little M.H. (2009) Stem cell options for kidney disease. J. Pathol. 217, 265281.
  • Horster M.F., Braun G.S., Huber S.M. (1999) Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol. Rev. 79, 11571191.
  • Huby A.C., Rastaldi M.P., Caron K., Smithies O., Dussaule J.C., Chatziantoniou C. (2009) Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS ONE 4, e6721.
  • Humphreys B.D., Lin S.J., Kobayashi A. et al. (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 8597.
  • Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341350.
  • Kalluri R. & Neilson E.G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 17761784.
  • Kitao A., Sato Y., Sawada-Kitamura S. et al. (2009) Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am. J. Pathol. 175, 616626.
  • Klahr S. & Morrissey J.J. (2000) The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int. Suppl. 75, S7S14.
  • Klahr S. & Morrissey J. (2003) Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int. Suppl. 87, S105S112.
  • Li J., Qu X., Bertram J.F. (2009) Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am. J. Pathol. 175, 13801388.
  • Liebner S., Cattelino A., Gallini R. et al. (2004) Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 166, 359367.
  • Lin S.L., Kisseleva T., Brenner D.A., Duffield J.S. (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 16171627.
  • Liu Y. (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 112.
  • Liu Y. & Yang J. (2006) Hepatocyte growth factor: new arsenal in the fights against renal fibrosis? Kidney Int. 70, 238240.
  • Liu Y., Wilkinson F.L., Kirton J.P. et al. (2007) Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 212, 1219.
  • Markwald R.R., Fitzharris T.P., Manasek F.J. (1977) Structural development of endocardial cushions. Am J Anat. 148, 85119.
  • Mauer M., Zinman B., Gardiner R. et al. (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N. Engl. J. Med. 361, 4051.
  • Modlinger P.S., Wilcox C.S., Aslam S. (2004) Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 24, 354365.
  • Nangaku M. (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 17, 1725. Epub 2005 Nov 16.
  • O’riordan E., Mendelev N., Patschan S. et al. (2007) Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am. J. Physiol. Heart. Circ. Physiol. 292, H285H294.
  • Remuzzi G., Benigni A., Remuzzi A. (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116, 288296.
  • Ruiz-Ortega M., Esteban V., Ruperez M. et al. (2006) Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr. Opin. Nephrol. Hypertens. 15, 159166.
  • Sugimoto H., Grahovac G., Zeisberg M., Kalluri R. (2007) Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56, 18251833. Epub 2007 Apr 24
  • Tharaux P.L., Chatziantoniou C., Fakhouri F., Dussaule J.C. (2000) Angiotensin II activates collagen i gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36, 330336.
  • Valderrabano F. & Berthoux F.C. (1996) Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. Nephrol. Dial. Transplant. 11(Suppl. 1), 221.
  • Vandermeersch S., Stefanovic V., Hus-Citharel A., Ardaillou R., Dussaule J.C., Chansel D. (2003) AT1 receptor expression in glomeruli from NO-deficient rats. Nephron Exp. Nephrol. 95, e119e128.
  • Wynn T.A. (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524529.
  • Yang J. & Liu Y. (2003) Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am. J. Physiol. Renal Physiol. 284, F349F357.
  • Yang J., Dai C., Liu Y. (2003) Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am. J. Pathol. 163, 621632.
  • Zeisberg M., Bottiglio C., Kumar N. et al. (2003a) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal Physiol. 285, F1060F1067.
  • Zeisberg M., Hanai J., Sugimoto H. et al. (2003b) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964968.
  • Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. (2007a) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 1012310128.
  • Zeisberg E.M., Tarnavski O., Zeisberg M. et al. (2007b) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952961. Epub 2007 Jul 29.
  • Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 22822287.